Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Eledon Pharmaceuticals Inc’s current trading price is -38.99% away from its 52-week high, while its distance from the 52-week low is 42.32%. The stock’s price range over this period has fluctuated between $2.38 and $5.54. The company, operating within the financial sector, had a trading volume of approximately 0.63 million for the day, which was noticeably higher than the average daily share volume of 0.5 million over the last 3 months.
The present stock price for Eledon Pharmaceuticals Inc (ELDN) is $3.38. In the last trading session, the stock made a considerable jump, reaching $12.0 after an opening price of $3.38. The stock briefly fell to $8.0 before ending the session at $3.15.
Eledon Pharmaceuticals Inc’s market performance has been unstable in recent times.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Eledon Pharmaceuticals Inc (ELDN) has experienced a quarterly rise of 3.05% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 202.40M and boasts a workforce of 31 employees.
Eledon Pharmaceuticals Inc: What Analysts Are Saying
As of right now, 6 analysts are rating Eledon Pharmaceuticals Inc as a BUY, 1 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 3.18, with a change in price of -0.21. Similarly, Eledon Pharmaceuticals Inc recorded 400,221 in trading volume during the last 100 days, posting a change of -5.85%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for ELDN stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.00.
ELDN Stock Stochastic Average
Today, Eledon Pharmaceuticals Inc’s raw stochastic average for the past 50 days stands at 52.53%, indicating a rise from the raw stochastic average of the last 20 days, which was 40.51%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 30.77% and 30.14% respectively.
ELDN Stock Price Performance Analysis
The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. The index has shown a price gain of 22.46% this year. Over the last six months, there has been a stronger performance of -29.29%. The price of ELDN fallen by 10.46% during the last 30 days period. For the last 5-days stocks have slided -6.63%.
